Economic evaluation for the UK of nab-paclitaxel plus gemcitabine in the treatment of metastatic pancreas cancer
Crossref DOI link: https://doi.org/10.1038/bjc.2015.65
Published Online: 2015-03-19
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gharaibeh, M
McBride, A
Bootman, J L
Abraham, I
Text and Data Mining valid from 2015-03-19
Article History
Received: 27 August 2014
Revised: 14 January 2015
Accepted: 27 January 2015
First Online: 19 March 2015